Health workers in Congo being vaccinated against Ebola: WHO
GENEVA (Reuters) – Vaccination of health workers against the deadly Ebola virus has begun in the Democratic Republic of Congo to try to halt an outbreak in the volatile east…
Latest Congo Ebola outbreak is Zaire strain, vaccinations to start
GENEVA (Reuters) – An Ebola outbreak in Congo has been confirmed as the Zaire strain of the virus and vaccinations of health workers may start as early as Wednesday, the…
Ebola vaccinations in eastern Congo due to begin on Wednesday
GOMA, Democratic Republic of Congo (Reuters) – Vaccinations against a new outbreak of Ebola virus in eastern Democratic Republic of Congo are due to begin on Wednesday, a senior official…
Eastern Congo Ebola outbreak believed to have killed 33: health ministry
DAKAR (Reuters) – An outbreak of the Ebola virus declared this week in eastern Democratic Republic of Congo is believed to have killed 33 people, the health ministry said on…
WHO warns there may be no vaccine option for new Ebola outbreak
GENEVA (Reuters) – It may be impossible to use a vaccine to tackle Democratic Republic of Congo’s new Ebola outbreak, which has spread over 10s of kilometers and may have…
Experts arrive in region of Congo’s new Ebola outbreak
GENEVA/GOMA (Reuters) – An international delegation has arrived in the town of Beni in Democratic Republic of Congo, 30 km (18 miles) from where an Ebola outbreak was declared, the…
More drugmakers build Brexit stockpiles as EU agency faces exodus
PARIS/ZURICH/LONDON (Reuters) – Sanofi (SASY.PA) and Novartis (NOVN.S) said on Wednesday they planned to increase stockpiles of medicines in Britain in preparation for potential disruption if the UK crashes out…
Factbox: Tributes paid to former Fiat Chrysler CEO Marchionne
(Reuters) – Former Fiat Chrysler Chief Executive Sergio Marchionne, one of the auto industry’s most tenacious and respected auto chiefs, has died, succumbing to complications from surgery. The carmaker’s controlling…
GSK’s new R&D head bets on genetics with $300 million 23andMe deal
LONDON (Reuters) – GlaxoSmithKline’s new research boss aims to turbo-charge the British group’s drug discovery engine with a $300 million bet on genetics by buying a stake in the Silicon…
Allergan, Molecular Partners eye drug meets main goal in two studies
(Reuters) – Allergan Plc and Molecular Partners AG said on Thursday their treatment for neovascular age-related macular degeneration, a leading cause of vision loss among people over 65, met the…